Metabolic dysfunction-associated steatotic liver disease in older adults is associated with frailty and social disadvantage.
Daniel I Clayton-ChubbWilliam W KempAmmar MajeedJohn S LubelRobyn L WoodsCammie TranJoanne RyanAlexander HodgeHans G SchneiderJohn J McNeilStuart Keith RobertsPublished in: Liver international : official journal of the International Association for the Study of the Liver (2023)
This study in a large cohort of relatively healthy community-dwelling older adults shows that MASLD is common, decreases with age and is associated with poorer metabolic health, social disadvantage and frailty.